Outcome of childhood acute lymphoblastic leukemia: A report of 121 patients treated at Wuhan Union Hospital of China

Chinese Medical Journal

Volumn 121, Issue 5, 2008, Pages 469-472

  Wang, Yan Rong ^a   Jin, Run Ming ^a   Xu, Jia Wei ^a   Xiao, Yan ^a   Zhou, Dong Feng ^a   Zhang, Zhi Quan ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Acute lymphoblastic leukemia; Childhood; Event free survival; Prognostic factor

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ETOPOSIDE; FOLINATE CALCIUM; IDARUBICIN; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; TENIPOSIDE; VINCRISTINE; VINDESINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CHILD; CHILDHOOD LEUKEMIA; CHINA; CHROMOSOME TRANSLOCATION 22; CHROMOSOME TRANSLOCATION 9; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOPHENOTYPING; INFANT; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKEMIA RELAPSE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSIS; SKULL IRRADIATION; LYMPHATIC LEUKEMIA; MORTALITY; NEWBORN; PRESCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TREATMENT OUTCOME;

EID: 42449122225     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200803010-00020     Document Type: Article

References (15)

1. Asgarian Omran H, Shabani M, Shahrestani T, Sarafnejad A, Khoshnoodi J, Vossough P, et al. Immunophenotypic subtyping of leukemic cells from Iranian patients with acute lymphoblastic leukaemia: association to disease outcome. Iran J Immunol 2007; 4: 15-25.
2. Schultz KR, Pullen DJ, Sather HN, Shuster JJ, Devidas M, Borowitz; MJ, et al. Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Childrens Cancer Group (CCG). Blood 2007; 109: 926-935.
3. Schrappe M, Reiter A, Zimmermann M, Harbott J, Ludwig WD, Henze G, et al. Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster.Leukemia 2000; 14: 2205-2222.
4. Gaynon PS, Trigg ME, Heerema NA, Sensel MG, Sather HN, Hammond GD, et al. Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995. Leukemia 2000: 14: 2223-2233.
5. Schrappe M, Camitta B, Pui CH, Eden T, Gaynon P, Gustafsson G, et al. Long-term results of large prospective trials in childhood acute lymphoblastic leukemia. Leukemia 2000; 14: 2193-2194.
6. Chauvenet AR, Martin PL, Devidas M, Linda SB, Bell BA, Kurtzberg J, et al. Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201. Blood 2007; 110: 1105-1111.
7. Tie LJ, Gu LJ, Chen J. Correlation between karyotypic characteristics and treatment outcome in childhood acute lymphoblastic leukemia. Chin J Hematol (Chin) 2006; 127: 339-343.
8. Coustan-Smith E, Sancho J, Hancock ML, et al. Clinical importance bf minimal residual disease in childhood acute lymphoblastic leukemia. Blood 2000; 96: 2691-2696.
9. Rubnitz JE, Pui CH. Recent advances in the treatment and understanding of childhood acute lymphoblastic leukaemia. Cancer Treat Rev 2003; 20: 31-44.
10. Gu LJ, Li J, Xue BL. Analysis of therapeutic effectiveness in 158 childhood acute lymphoblastic leukemia patients treated with ALL-XH-99 protocol. Chin J Hematol (Chin) 2004; 25: 1-4.
11. Pui CH, Cheng C, Leung W. Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia. N Engl J Med 2003; 349: 640-649.
12. Burger B, Zimmermann M, Mann G. Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture. J Clin Oncol 2003; 21: 194-188.
13. Clarke M, Gaynon P, Hann I. CNS-directed therapy for childhood acute lymphoblastic leukemia: Childhood ALL Collaborative Group overview of 43 randomized trials. J Clin Oncol 2003; 21: 1798-1809.
14. Pui CH, John TS, Pei DQ. Improved outcome for children with acute lymphoblastic leukemia: results of total therapy study XIIIB at St Jude children's research hospital. Blood 2004; 104: 2690-2696.
15. Pui CH, Relling MV. Topoisomerase II inhibitor-related acute myeloid leukaemia. Dr J Haematol 2000; 109: 13-23.